As of May 27
| +0.095 / +0.73%|
The 1 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a -42.86% decrease from the last price of 13.13.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.